Yahoo · Oct 2, 2026
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Veeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close.

NYSE · VEEV
Healthcare · Medical - Healthcare Information Services
$296.13
Up+$11.29 (+3.96%)
Updated Oct 10, 2026, 7:12 PM
SID Score
7.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · VEEV
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
VEEV closed at $296.13 after 21 trading sessions, up 12.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $285.71 | $297.45 | $284.00 | $296.13 | 1.85M |
| Oct 8, 2026 | $282.13 | $285.245 | $279.0201 | $284.84 | 922.1K |
| Oct 7, 2026 | $284.23 | $286.98 | $279.795 | $282.50 | 1.12M |
| Oct 6, 2026 | $285.34 | $289.87 | $282.2628 | $283.50 | 1.17M |
| Oct 5, 2026 | $275.00 | $283.47 | $274.00 | $283.45 | 1.32M |
| Oct 2, 2026 | $283.10 | $284.59 | $272.835 | $273.33 | 1.08M |
| Oct 1, 2026 | $291.40 | $291.40 | $281.79 | $281.93 | 961.89K |
| Sep 30, 2026 | $277.85 | $288.41 | $275.70 | $285.45 | 1.76M |
| Sep 29, 2026 | $278.50 | $282.2424 | $273.92 | $278.57 | 1.1M |
| Sep 28, 2026 | $275.08 | $282.04 | $272.54 | $279.96 | 1.38M |
| Sep 25, 2026 | $276.84 | $282.81 | $275.91 | $280.68 | 1.74M |
| Sep 24, 2026 | $270.91 | $276.24 | $270.68 | $274.84 | 1.38M |
| Sep 23, 2026 | $263.25 | $272.18 | $262.995 | $270.75 | 1.43M |
| Sep 22, 2026 | $265.80 | $265.80 | $259.34 | $260.91 | 1.82M |
| Sep 21, 2026 | $260.00 | $264.42 | $257.87 | $261.31 | 1.2M |
| Sep 18, 2026 | $263.40 | $263.745 | $259.09 | $260.21 | 6M |
| Sep 17, 2026 | $263.44 | $266.71 | $260.45 | $263.75 | 1.12M |
| Sep 16, 2026 | $265.27 | $267.96 | $262.44 | $264.90 | 1.11M |
| Sep 15, 2026 | $260.80 | $272.3899 | $258.01 | $266.62 | 1.35M |
| Sep 14, 2026 | $264.93 | $267.4233 | $260.56 | $265.67 | 1.36M |
| Sep 11, 2026 | $261.81 | $263.69 | $259.54 | $262.40 | 863.8K |
The latest Smart Investors Daily articles mentioning VEEV.
Company
Market Activity
Research & News
VEEV research
Company profile and research snapshot.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 28, 2026 | Citigroup | Neutral | — |
| Aug 27, 2026 | UBS | Neutral | — |
| Aug 27, 2026 | Barclays | Overweight | — |
| Aug 27, 2026 | TD Cowen | Buy | — |
| Aug 27, 2026 | Canaccord Genuity | Hold | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
Veeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close.
Yahoo · Oct 1, 2026
Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.
Yahoo · Oct 1, 2026
Veeva Systems is making that transformation happen. The Pleasanton, Calif.–based company develops software for biotechnology and pharmaceutical customers to manage everything from research and development and regulatory submissions to day-to-day commercial operations. Its software was originally built atop Salesforce but has since expanded to stand-alone applications.
Yahoo · Oct 1, 2026
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning VEEV.